Pittsburgh and Allegheny County have joined the growing number of governments that have sued drug manufacturers and distributors for the role they’ve played in fostering the opioid crisis.

Big Pharma has deep pockets, and legal experts are talking about the possibility of an industrywide settlement, similar to the 1998 landmark deal with tobacco companies. It could yield huge sums for opioid prevention, treatment programs and law enforcement.

If drug manufacturers and their subsidiaries flooded communities with opioids in spite of the risks, as many of the suits claim, government lawyers should wring every last penny they can from them. Municipalities, including Pittsburgh and its suburbs, should get their share.

But the pursuit of money cannot overshadow other important goals. Prosecutors must seek charges against any drug company or executive whose pill-pushing violated criminal law, and the various lawsuits and investigations must be viewed as a watershed opportunity to reform the culture of a pharmaceutical industry with a long reach.

Advertise with us

If drug companies put profits ahead of public health where opioids are concerned, they’ll do it with other medications, too. That might mean marketing a higher-priced drug instead of a more effective but cheaper one or sitting on medications that heal so manufacturers can continue making money on those that manage a disease. This is the time for regulators, elected officials, consumers and especially those hurt by opioids to alter the industry’s DNA.

As Rebecca L. Haffajee  and Michelle M. Mello wrote in December in The New England Journal of Medicine, “Win or lose, lawsuits that very publicly paint the opioid industry as contributing to the worst drug crisis in American history put wind in the sails of agencies and legislatures seeking stronger oversight.”

Allegheny County Executive Rich Fitzgerald showed an understanding of this Tuesday when he said the suit against eight drug companies “is about changing the way the opioid industry does business.” It will be difficult to maintain that focus, however, if hundreds of suits nationwide get bundled into a global settlement, litigants begin scrapping for their pieces of the pie and the industry exploits the scenario to avoid responsibility. If big numbers start to fly around  —  remember, the tobacco settlement is to yield $206 billion over 25 years — it will be easy to lose sight of the ball.

The tobacco industry admitted no wrongdoing in its settlement with 46 states. When it comes to opioids, that won’t fly. Culpability should be the centerpiece of any settlement, or let the plaintiffs take their cases to trial. Also, no settlement should short-circuit any criminal investigation into the drug companies’ actions.

A hefty settlement would help municipalities care for those in the throes of addiction and prevent others from becoming victims. Holding drugmakers accountable and reforming the industry are what government owes those who lost their battles.